Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Soligenix Inc (OTCBB - OTCQB:SNGX)

1.32
Delayed Data
As of Aug 28
 +0.07 / +5.60%
Today’s Change
0.91
Today|||52-Week Range
2.95
+34.76%
Year-to-Date
No recent news for Soligenix Inc.

Today’s Trading

Previous close1.25
Today’s open1.29
Day’s range1.23 - 1.34
Volume69,218
Average volume (3 months)215,360
Market cap$34.8M
Dividend yield--
Data as of 3:56pm ET, 08/28/2015

Growth & Valuation

Earnings growth (last year)+33.85%
Earnings growth (this year)-18.60%
Earnings growth (next 5 years)+1.00%
Revenue growth (last year)+118.45%
P/E ratioNM
Price/Sales3.28
Price/Book--

Competitors

 Today’s
change
Today’s
% change
ROSGRosetta Genomics Ltd0.000.00%
OXGNOXiGENE Inc+0.02+1.72%
KDUSCadus Corp0.000.00%
ENZBEnzymeBioSystems-0.01-0.42%
Data as of 3:43pm ET, 08/28/2015

Financials

Next reporting dateNovember 13, 2015
EPS forecast (this quarter)-$0.08
Annual revenue (last year)$7.0M
Annual profit (last year)-$6.7M
Net profit margin-95.23%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman, President &
Chief Executive Officer
Christopher J. Schaber
Chief Financial Officer, Secretary &
VP
Joseph Michael Warusz
Corporate headquarters
Princeton, New Jersey

Forecasts

Partner Offers